DiaMedica

calendar hour glass wait delay months

Biotech

DiaMedica prepares to end 10-month stroke hold by halving dose

DiaMedica Therapeutics thinks it has the data to get out from under a stubborn FDA clinical hold for its stroke medication.

Nick Paul Taylor May 16, 2023 9:20am

IV intravenous drip

No remedy for DiaMedica as FDA maintains hold on stroke trial

Oct 27, 2022 9:30am

Nasdaq

DiaMedica pulls off IPO to fund midphase stroke trial

Dec 7, 2018 9:35am